SAT-430 A Phase 1 Study in Healthy Volunteers to Assess the Safety, Tolerability, and Pharmacokinetics of ONO-5788: A Novel Oral Small Molecule Somatostatin Receptor Type-2 Agonist

Lignende værker

• MON-464 Non-Clinical Profiling of ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, to Support Studies in Humans
  af: Komagata, Tatsuya, et al.
  Udgivet: (2019)
• MON-459 ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, Attenuates GH Hypersecretion in Human GH-Secreting, Pituitary Adenoma-Derived Cells
  af: Zhou, Cuiqi, et al.
  Udgivet: (2019)
• SAT-465 Somatostatin Receptor Ligand as Initial Therapy in a Patient with Pituitary Microadenoma and Acromegaly: Temporary Remission and Recurrence
  af: Baby, Ann, et al.
  Udgivet: (2019)
• MON-477 Octreotide and ONO-ST-468, a Novel and Potent Somatostatin Receptor Type-2 (SST2) Agonist, Suppress GH Hypersecretion in the Monkey
  af: Tanaka, Hirotaka, et al.
  Udgivet: (2019)
• MON-430 To B, or Not to B
  af: Pradeep, Pallavi, et al.
  Udgivet: (2019)